Overview

Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)

Status:
Recruiting
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
This trial is an exploratory study, aiming to explore the preliminary efficacy and safety of Kesuting Syrup in the treatment of novel coronavirus pneumonia. It is planned to include a total of 200 cases. Kesuting Syrup test group: Lianhua Qingwen Granules control group = 1:1, each 100 cases in each group.
Phase:
Phase 4
Details
Lead Sponsor:
Guizhou Bailing Group Pharmaceutical Co Ltd